Pharmacy Industry Leaders Gather to Discuss Most Favored Nation Drug Policy

The Most Favored Nation drug policy, often shortened to MFN, is an executive order that requires drug manufacturers to sell drugs at a price no higher than the lowest price offered for that specific drug across various developed countries. While the core functions of this policy may be ideal for patients and their access to prescription drugs, experts are significantly uncertain as to how the MFN policy will actually be implemented.